Rigel Pharma (RIGL) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $42.02 +0.86%
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
WPRT, ITRG, ALM, More
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
WPRT, ITRG, ALM, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q4 EPS of ($0.16), $0.01 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $3 million versus the consensus estimate of $4.25 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
- National CineMedia (NCMI) Misses Q2 EPS by 7c
- Immunome, Inc. (IMNM) Reports Q2 Loss of $0.65
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
